68695-48-7

Basic information

• Product Name: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT
• Synonyms: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT;Tetra-n-butylammonium Di-tert-butylphosphate;Tetrabutylammonium di-tert-butyl phosphate;di-tert-butyl phosphate, di-tert-butylphosphate;di-tert-butyl phosphoric acid tetra-n-butylammonium salt, tetra-n-butylammonium di-tert-butylphosphate, tetrabuthylammonium di-tert-butyl-phosphate, tetrabutylammonium di-tert-butyl phosphate, tetrabutylammonium di-tert-butylphosphate, tetrabutylammonium;tetrabutylammonium salt
• CAS NO: 68695-48-7
• Molecular Formula: C₈H₁₈O₄P*C₁₆H₃₆N
• Molecular Weight: 451.663621
• Mol File: 68695-48-7.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(CAS DataBase Reference)
• NIST Chemistry Reference: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(68695-48-7)
• EPA Substance Registry System: DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT(68695-48-7)

Safety Data

• Hazardous Substances Data: 68695-48-7(Hazardous Substances Data)

Usage

Uses

Used in Chemical Extraction Processes:
DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT is used as a solvent or extractant for its ability to dissolve and selectively separate various compounds, particularly in the extraction of rare earth metals from ores. Its affinity for metal ions and organic compounds facilitates efficient separation and purification processes.
Used in Battery Technology:
In the battery industry, DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT serves as an electrolyte, contributing to the performance and stability of certain types of batteries. Its chemical properties enhance ionic conductivity and contribute to the overall efficiency of the battery system.
Used in Environmental Management:
Given its potential toxicity and environmental impact, DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT also has applications in environmental management, where it is used with caution and proper handling protocols to minimize ecological harm during its use in industrial processes.
It is crucial to handle DI-TERT-BUTYLPHOSPHATE, TETRABUTYLAMMONIUM SALT with care due to its toxic nature, ensuring that it is managed responsibly to prevent adverse effects on both human health and the environment.

InChI:InChI=1/C16H36N.C8H19O4P/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4;1-7(2,3)11-13(9,10)12-8(4,5)6/h5-16H2,1-4H3;1-6H3,(H,9,10)/q+1;/p-1

Upstream product

• 33494-80-3 potassium di-tert-butylphosphate 
• 13086-84-5 di-tert-butyl phosphite 
• 33494-81-4 phosphoric acid di-tert-butyl ester 
• 2052-49-5 tetra(n-butyl)ammonium hydroxide 
• 32503-27-8 tetra(n-butyl)ammonium hydrogensulfate 
• 13086-84-5 di-tert-butyl phosphite 

Downstream Products

• 1367455-49-9 [2-[2-amino-4-(isoindoline-2-carbonyl)quinazolin-6-yl]-4,5-difluorophenyl]methyl di-tert-butyl phosphate 
• 3393-77-9 bis(4-methoxyphenyl)sulfide 
• 110348-50-0 4-Methoxy-benzenethiolatetetrabutyl-ammonium; 
• 885228-14-8 benzyl (2-((di-tert-butoxyphosphoryl)oxy)ethyl)carbamate 
• 1401907-80-9 methyl 3-(((di-tert-butoxyphosphoryl)oxy)methyl)benzoate 
• 1584715-93-4 ((S)-3-((R)-2-((S)-1-amino-3-cyclopropyl-1-oxopropan-2-yl)-5,5,5-trifluoropentanamido)-9-fluoro-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-1-yl)methyl di-tert-butyl phosphate 
• 130985-36-3 (benzyloxycarbonyl)methyl di-tert-butyl phosphate 

Relevant articles and documents

4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator

Compounds and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK1) receptor, based on 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)3yridine-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium and pharmaceutically acceptable salts thereof.

SUBSTITUTED 4-PHENYL-PYRIDINES FOR TREATMENT OF NK-1 RECEPTOR RELATED DISEASES

PROBLEM TO BE SOLVED: To provide new derivatives of 4-phenyl-pyridine compounds that are effective NK1 receptor antagonists, with enhanced physicochemical and/or biological properties, and methods for producing the 4-phenyl-pyridine compounds. SOLUTION: Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NKj) receptor. The compounds have the general formula (I). COPYRIGHT: (C)2015,JPOandINPIT

PHENYLQUINAZOLINE DERIVATIVES

Novel quinazolinamide derivatives of the formula (I), in which R1-R43 and X have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF

Compounds of formula (IA) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

MONO-LYSINE SALTS OF AZOLE COMPOUNDS

Mono-lysine salts of triazole compounds having a secondary or tertiary hydroxy group are provided. More particularly, the new water-soluble triazole antifungal mono-lysine salt compounds, or solvates thereof, are provided having the general formula I: wherein A in formula I represents the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group. R and R1 in formula I can each be a hydrogen atom or an alkyl group having one to six carbon atoms. The novel water-soluble azole compounds are useful for the treatment of fungal infections and can be administered orally, topically and parenterally.

Process for water soluble azole compounds

An improved process is provided for preparing water-soluble prodrugs of triazole antifungal compounds containing a secondary or tertiary hydroxyl group. More particularly, the improved process is directed toward preparation of water-soluble triazole antifungal compounds are provided having the general formula wherein A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group and R and R1 are as defined in the specification.

Water soluble prodrugs of azole compounds

Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided. More particularly, new water-soluble triazole antifungal compounds are provided having the general formula wherein A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group and R and R1 are as defined in the specification.